Budesonide is not beneficial for the treatment of diarrhoea in metastatic melanoma patients

Patients with stage III or IV melanoma taking ipilimumab and the oral steroid budesonide to reduce side effects did not have less diarrhoea, a known side effect of ipilimumab, according to results of a phase II trial published in Clinical Cancer Research, a journal of the American Association for Cancer Research...

Read the whole article on

More from